Healthcare Sales & Marketing Network News: psychotic major depression

Searching News Database: psychotic major depression

HSMN NewsFeed - 30 Mar 2007
Corcept Therapeutics Announces $9 Million Private Equity Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Mar 2007
Corcept Therapeutics Announces Phase 3 Study Evaluating CORLUX(R) for Psychotic Major Depression Misses Primary Endpoint
Biopharmaceuticals

HSMN NewsFeed - 13 Nov 2006
Corcept Therapeutics Completes Enrollment in Third Phase 3 Study for Treating Psychotic Major Depression
Biopharmaceuticals

HSMN NewsFeed - 29 Sep 2006
Corcept Therapeutics Announces Negative Results From the Second of Three Phase 3 Studies Evaluating CORLUX(R) for Treating the Psychotic Features of Psychotic Major Depression
Biopharmaceuticals

HSMN NewsFeed - 25 Aug 2006
Corcept Therapeutics Announces Negative Results From the First of Three Phase 3 Studies Evaluating CORLUX(R) for Treating the Psychotic Features of Psychotic Major Depression
Biopharmaceuticals

HSMN NewsFeed - 22 May 2006
Corcept Therapeutics Completes Enrollment in Second Phase 3 Study for Treating Psychotic Major Depression
Biopharmaceuticals

HSMN NewsFeed - 1 May 2006
Corcept Therapeutics Completes Enrollment in Phase 3 Study for Treating Psychotic Major Depression
Biopharmaceuticals

Return to NewsFeed

Additional items found! 3

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 3 additional stories matching:
psychotic major depression
(Password required)

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.